Related Experiment Video
Updated: Jan 28, 2026

Perspectives on Neuroscience
Published on: July 31, 2007
Immunotherapy: Current Status and Future Perspectives
Charalampos S Floudas1, Gagandeep Brar2, Tim F Greten2,3
1Gastrointestinal Malignancy Section, Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Rm B2L312, 10 Center Drive, Bethesda, MD, 20892-1078, USA. charalampos.floudas@nih.gov.
Abstract:
Hepatocellular carcinoma (HCC) has an increasing incidence and dismal prognosis, with few systemic treatments approved, including several small molecule tyrosine kinase inhibitors. The application of immune checkpoint inhibitors (ICIs) to HCC has resulted in durable activity, and further evaluation is ongoing. In this review, we discuss the immunologic principles and the mechanism of action of the ICIs and present the relevant clinical data. Furthermore, we provide an overview of the current and emerging immunotherapeutic approaches for HCC, such as combination treatments, vaccines, and cellular therapies.
Related Concept Videos
Tumor Immunotherapy
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
The Behavioral Perspective on Personality
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
Social Cognitive Perspective on Personality
Marcia's Theory of Identity Status

